Allergen immunotherapy: clinical and practical education of Italian trainees in allergy and clinical immunology schools

被引:0
|
作者
Ridolo, E. [1 ]
Incorvaia, C. [2 ]
Senna, G. E. [3 ]
Montagni, M. [1 ]
Olivieri, E. [1 ]
Canonica, G. W. [4 ]
机构
[1] Univ Parma, Dept Clin & Expt Med, Via Gramsci 14, I-43100 Parma, Italy
[2] ICP Hosp, Allergy Pulm Rehabil, Milan, Italy
[3] Verona Gen Hosp, Allergy Unit, Verona, Italy
[4] Univ Genoa, DIMI, Allergy & Resp Dis, Genoa, Italy
关键词
Allergen immunotherapy; allergology; clinical immunology; survey; trainee;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
We performed a survey, based on a questionnaire including 20 items, submitted anonymously to Italian trainees in Allergology and Clinical Immunology, in order to obtain information about their specific allergen immunotherapy (AIT) practices. The questionnaire was sent to 40 trainees, who had attended the last two years of the training course. Thirty-four subjects (mean age: 27 years, 65% females) adequately completed the survey. The answers to the questionnaire showed that only 60% of the training programs included lectures on AIT. Among the trainees using AIT, only 40% declared being able to prescribe it independently, while 60% were guided by a tutor. Of the trainees who were able to prescribe AIT autonomously, 60% were familiar with both routes of administration, i.e. subcutaneous (SCIT) and sublingual immunotherapy (SLIT), while 25% of these used only SLIT. In 80% of the training institutions involved, the trainees could attend a dedicated AIT outpatient ward for SCIT administration; only 40% administered AIT personally, and in half of these cases, they were guided by a tutor. Only 70% of trainees had experience in the follow-up of patients still under treatment and of patients who had completed treatment. Analysis of the answers obtained for questions on venom immunotherapy (VIT) showed that, in 90% of cases, the trainees attended a dedicated outpatients ward where VIT is administered, but with a role limited to observation/cooperation. Only 30% were involved in the followup of patients who were under treatment or who had completed VIT. Only 20% of the trainees felt confident enough about VIT to prescribe this treatment independently, 80% knew there were several administration protocols, and the majority prescribed products from three different manufacturers. These findings suggest that there is significant room for improving the instructions provided regarding allergology and clinical immunology to trainees in Italy with respect to AIT.
引用
收藏
页码:49 / 52
页数:4
相关论文
共 50 条
  • [21] Allergy and Clinical Immunology Preface
    Kidon, Mona Iancovici
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (12): : 835 - 836
  • [23] State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)
    Jensen-Jarolim, Erika
    Bachmann, Martin F.
    Bonini, Sergio
    Jacobsen, Lars
    Jutel, Marek
    Klimek, Ludger
    Mahler, Vera
    Moesges, Ralph
    Moingeon, Philippe
    O'Hehir, Robyn E.
    Palomares, Oscar
    Pfaar, Oliver
    Renz, Harald
    Rhyner, Claudio
    Roth-Walter, Franziska
    Rudenko, Michael
    Savolainen, Johannes
    Schmidt-Weber, Carsten B.
    Traidl-Hoffmann, Claudia
    Kuendig, Thomas
    ALLERGY, 2020, 75 (04) : 746 - 760
  • [25] CLINICAL EFFICACY OF ALLERGEN IMMUNOTHERAPY
    PATTERSON, R
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1979, 64 (03) : 155 - 158
  • [26] CLINICAL EFFICACY OF ALLERGEN IMMUNOTHERAPY
    MALLING, HJ
    ISI ATLAS OF SCIENCE-IMMUNOLOGY, 1988, 1 (3-4): : 215 - 219
  • [27] Allergy/Immunology Electives Using the AAAAI Clinical Rotation Curriculum Are Highly Valued By Medical Trainees
    Lee, Gerald B.
    Scherzer, Rebecca
    Scholfield, Andrea L.
    Mosnaim, Giselle
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB281 - AB281
  • [28] Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies-Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce
    Asllani, Julijana
    Mitsias, Dimitrios
    Konstantinou, George
    Mesonjesi, Eris
    Xhixha, Fatmira
    Shehu, Esmeralda
    Christoff, George
    Noleva, Katia
    Makris, Michael
    Aggelidis, Xenofon
    Turkalj, Mirjana
    Damir, Erceg
    Agache, Ioana
    Tomic-Spiric, Vesna
    Stosovic, Rajica
    Misirligil, Zeynep
    Kosnik, Mitja A.
    Popov, Todor
    Calderon, Moises G.
    Papadopoulos, Nikolaos
    CLINICAL AND TRANSLATIONAL ALLERGY, 2023, 13 (06)
  • [29] Developmental immunology: clinical application to allergy-immunology
    Bellanti, JA
    Malka-Rais, J
    Castro, HJ
    de Inocencio, JM
    Sabra, A
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 90 (06) : 2 - 6
  • [30] Current reviews of allergy and clinical immunology
    Norman, PS
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (06) : 1013 - 1023